The Therapeutic Goods Administration (TGA) has confirmed a shortage of Prednefrin Forte 10mL eye drops in Australia, which isn't expected...
Read moreAn independent expert panel has recommended Novartis' treatment Beovu be subsidised through the Pharmaceutical Benefits Scheme (PBS) for neovascular age-related...
Read moreTwo years since the KeepSight launch, Insight asks what measurable difference this once-in-a-generation program is making to those living with...
Read moreNova Eye Medical has published two-year data for its iTrack ab-interno canaloplasty procedure, which it says showed an average reduction...
Read moreThe term ‘quarantine myopia’ has been coined to describe what appears to be a worsening of the condition in many...
Read moreThe managing director of one of Australia’s pre-eminent eye research institutions is a leading scientist behind experiments on mice that...
Read moreA new diabetic eye clinic for children in Western Australia, which opened last month, is part of the Lions Eye Institute's first major...
Read moreNova Eye Medical has announced positive five-year follow-up data from a sub-study analysis of the multi-centre LEAD trial for its...
Read moreAdvances in glaucoma stent technology far outstripped the Medicare schedule early on, creating a disconnect that had far-reaching consequences. As...
Read moreNova Eye Medical has announced eight surgery centres across the US have commenced a prospective, randomised clinical trial to assess...
Read moreInsight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited
© 2024 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited